Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke

Ticagrelor, acting as a reversible platelet aggregation inhibitor of P2Y12 receptors (P2Y12R), is regarded as one of the first-line antiplatelet drugs for acute cardiovascular diseases. Though the probability of ticagrelor resistance is much lower than that of clopidogrel, there have been recent rep...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Song, Lin, Yapeng, Tan, Quandan, Mao, Fengkai, Chen, Kejie, Hao, Junli, Le, Weidong, Yang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918175/
https://www.ncbi.nlm.nih.gov/pubmed/36769796
http://dx.doi.org/10.3390/jcm12031149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918175/
https://www.ncbi.nlm.nih.gov/pubmed/36769796
http://dx.doi.org/10.3390/jcm12031149

Ejemplares similares